Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Revlimid in older patients with untreated AML without 5q abnormalities
NCT00546897Phase 2Completed
- Sponsor
- Washington University School of Medicine
- Start
- Feb 2007
- Primary completion
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lenalidomide in acute myeloid leukemia (AML), sponsored by Washington University School of Medicine. Started Feb 2007; status: completed.
02
Drugs
lenalidomide
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT00546897.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00546897.